Cleared Traditional

K810308 - ARTERIAL MICROCOLLECTION SET

K810308 is the FDA 510(k) clearance for ARTERIAL MICROCOLLECTION SET by American Dade. It is a Class 2 Hematology device (product code CHL) cleared through the Traditional 510(k) pathway after a 14-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1981
Decision
14d
Days
Class 2
Risk

K810308 is an FDA 510(k) clearance for the ARTERIAL MICROCOLLECTION SET. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by American Dade (Mchenry, US). The FDA issued a Cleared decision on February 19, 1981 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.1120 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Dade devices

Submission Details

510(k) Number K810308 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 05, 1981
Decision Date February 19, 1981
Days to Decision 14 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
99d faster than avg
Panel avg: 113d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 118
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K810308.
158 BLOOD GAS ANALYZER
K820597 · Corning Medical & Scientific · Mar 1982
CLEANING SOLUTION FOR RADIOMETER OSM2
K812623 · Fisher Scientific Co., LLC · Nov 1981
CORNING 178 BLOOD GAS ANALYZER
K810724 · Corning Medical & Scientific · Mar 1981
IL MODEL 1303 PH/BLOOD GAS ANALYZER
K800757 · Instrumentation Laboratory CO · Apr 1980
BLOOD GAS SYSTEM MODEL 168
K781968 · Corning Medical & Scientific · Jan 1979
TECHNICON BGII ANALYZER
K780716 · Technicon Instruments Corp. · Jun 1978